DKCM
PRVL

Davidson Kempner Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Davidson Kempner Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70,000
Closed -$936K – 223
2019
Q2 		$936K Buy
+70,000
New +$936K 0.01% 140